[1]
A. Lescano, “Long-term effect of subcutaneous treprostinil in patients with pulmonary hypertension: rationale and design of the phase IV, multicentre, observational TREPAR-HP study”, Int J Clin Trials, vol. 9, no. 3, pp. 174–182, Jul. 2022.